Skip to main content
Premium Trial:

Request an Annual Quote

NorayBio Licenses Noraynet to BioDynamics

NEW YORK (GenomeWeb News) - NorayBio licensed its biopharmaceutical platform to BioDynamics, NorayBio said today.
 
The platform, Noraymet ADME, predicts human pharmacokinetic models of new compounds from in vitro ADME data.
 
NorayBio has licensed the product to Spain's Faes Farma and Finland's Novamass.
 
NorayBio and BioDynamics also plan to co-develop software based on Noraymet ADME to refine human pharmacokinetic modelling.

Filed under

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.